Stocks Health care CALC
NASDAQ · Health careCalciMedica, Inc. (CALC)
It posted a net loss of $21.2M. In fiscal 2025 capital spending exceeded operating cash flow by $21.2M. At June 30, 2026 it held $18.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Key facts about CalciMedica, Inc.
- Net worth
- CalciMedica, Inc. has a market value (market cap) of $44.3M at the latest share price, and shareholders' equity of $5.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $21.2M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- CalciMedica, Inc.'s next report was expected around November 11, 2026 and is not on file with the SEC yet.
What CalciMedica, Inc. does
CalciMedica, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CALC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$29.6M | -$1.97 | -$21.2M |
| 2024 | n/a | -$13.7M | -$1.22 | -$21.2M |
| 2023 | n/a | -$34.4M | -$7.66 | -$25.8M |
| 2022 | n/a | -$7.8M | -$111.16 | -$11.8M |
| 2021 | n/a | -$35.8M | -$113.17 | -$32M |
| 2020 | n/a | -$27.5M | -$351.56 | -$33.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What CalciMedica, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 30, 2026Other event 8-K
- September 23, 2026
- September 16, 2026Other event 8-K
- September 2, 2026Other event 8-K
- August 27, 2026
- August 25, 2026Passive stake (5% or more) SCHEDULE 13G
- August 24, 2026Activist stake changed SCHEDULE 13D/A
- August 21, 2026Activist stake changed SCHEDULE 13D/A
- August 20, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running CalciMedica, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 25, 2026 | Wilson Robert NDirector | Received as pay | 1,182,621 | $950K |
| June 25, 2026 | Middleton Fred ADirector, 10% owner | Boughtindirect | 248,972 | $200K |
| June 25, 2026 | Leheny A. RachelCHIEF EXECUTIVE OFFICER, Director, 10% owner | Received as pay | 186,729 | $150K |
| June 25, 2026 | Roberts Eric WCHIEF BUSINESS OFFICER, Director, 10% owner | Received as pay | 186,729 | $150K |
| June 25, 2026 | Hebbar SudarshanChief Medical Officer | Received as pay | 124,486 | $100K |
Who owns CALC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Alafi Capital Company LLC13D, may seek influence with 1 related filers | 19.9% | August 24, 2026 |
| Armistice Capital, LLC13G, passive with 1 related filers | 9.99% | August 14, 2026 |
| Bering Partners II GP, L.L.C.13D, may seek influence with 3 related filers | 9.99% | August 21, 2026 |
| A. Rachel Leheny13D, may seek influence with 4 related filers | 9% | November 6, 2024 |
| Woodline Partners LP13G, passive | 8.1% | August 14, 2026 |
| Eric W. Roberts13D, may seek influence with 4 related filers | 6.4% | June 30, 2026 |
| Stonepine Capital Management, LLC13G, passive with 3 related filers | 6% | August 25, 2026 |
| CVI Investments, Inc.13G, passive with 1 related filers | 5.1% | July 20, 2026 |
Largest institutional holders
Insiders
5 insiders reported holding 3,538,037 shares in total, about $4.6M at the last price.
| Holder | Shares |
|---|---|
| Wilson Robert NDirector | 1,604,650 |
| Middleton Fred ADirector, 10% owner | 1,063,2721,063,272 held indirectly |
| Roberts Eric WCHIEF BUSINESS OFFICER, Director, 10% owner | 366,435 |
| Leheny A. RachelCHIEF EXECUTIVE OFFICER, Director, 10% owner | 317,655 |
| Hebbar SudarshanChief Medical Officer | 186,025 |
Questions about CALC
What does CalciMedica, Inc. do?
CalciMedica, Inc. is a company in the Health care sector, listed on NASDAQ as CALC. Its shares trade on NASDAQ under the ticker CALC.
What is CalciMedica, Inc.'s net worth?
CalciMedica, Inc. has a market value (market cap) of $44.3M at the latest share price, and shareholders' equity of $5.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is CalciMedica, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $21.2M.
When did CalciMedica, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 5, 2026.
When is CalciMedica, Inc.'s next earnings report?
CalciMedica, Inc.'s next report was expected around November 11, 2026 and is not on file with the SEC yet.
Similar companies
Compare CALC with
Follow CALC
Get an email when CalciMedica, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values CalciMedica, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.